港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

腦動極光-B

5.880

-0.100-1.67%

成交量：64.00萬

成交額：384.67萬

市值：74.44億

市盈率：-25.22

高：6.080

開：5.980

低：5.880

收：5.980

資料載入中...

總覽公司新聞公告

“中國數字療法第一股”？腦動極光問題明顯，時間是不安之源

腦動極光：3年半虧損近17億商業化早期難掩盈利焦慮

新股解讀|腦動極光：3年半虧損近17億商業化早期難掩盈利焦慮

新股消息丨腦動極光通過港交所聆訊深耕認知障礙數字療法市場

腦動極光通過港交所聆訊深耕認知障礙數字療法市場

新股消息丨腦動極光通過港交所聆訊深耕認知障礙數字療法市場

腦動極光通過上市聆訊：上半年營收5189萬虧損1.14億

腦動極光-B再次通過聆訊或很快香港上市中金、浦銀聯席保薦

腦動極光上市聆訊獲通過擬於港交所主板上市

中国上市公司网

【新股IPO】腦動極光醫療科技通過港交所上市聆訊

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06681/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06681","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06681\",,,,,undefined,":{"symbol":"06681","market":"HK","secType":"STK","nameCN":"腦動極光-B","latestPrice":5.88,"timestamp":1744877289037,"preClose":5.98,"halted":0,"volume":640000,"delay":0,"floatShares":1266000000,"shares":1266000000,"eps":-0.23313061225947168,"marketStatus":"復活節星期一休市","change":-0.1,"latestTime":"04-17 16:08:09","open":5.98,"high":6.08,"low":5.88,"amount":3846730,"amplitude":0.033445,"askPrice":6,"askSize":23000,"bidPrice":5.88,"bidSize":6000,"shortable":0,"etf":0,"ttmEps":-0.24279353958286434,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1736265600000,"exchange":"SEHK","adjPreClose":5.98,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.9310445155794449,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06681\",,,,,undefined,":{"symbol":"06681","floatShares":1266000000,"roa":"-23.24%","roe":"--","lyrEps":-0.233131,"volumeRatio":0.9310445155794449,"shares":1266000000,"dividePrice":0,"high":6.08,"amplitude":0.033445,"preClose":5.98,"low":5.88,"week52Low":3.13,"pbRate":"-15.10","psRate":"57.25","week52High":7.81,"institutionHeld":0,"latestPrice":5.88,"committee":-0.586207,"eps":-0.23313061225947168,"divideRate":0,"volume":640000,"delay":0,"ttmEps":-0.24279353958286434,"open":5.98,"prevYearClose":3.22,"prevWeekClose":5.88,"prevMonthClose":7.29,"prevQuarterClose":7.29,"fiveDayClose":6.22,"twentyDayClose":7.18,"sixtyDayClose":3.72},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06681\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2484674030","title":"“中國數字療法第一股”？腦動極光問題明顯，時間是不安之源","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674030","media":"深潜atom","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484674030?lang=zh_tw&edition=fundamental","pubTime":"2024-11-18 10:08","pubTimestamp":1731895730,"startTime":"0","endTime":"0","summary":"2020年，国家药品监督管理局审批通过了首款数字疗法产品，加速了该赛道的发展。在此后的2021年，疫情的推动、资本市场的支持以及政策和技术的进步共同作用下，数字疗法呈现井喷状态，甚至被称为数字疗法元....","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OTaWN-yeCAqiOI9rf8heM_q3a_qfqjca4uQ3VbQ7W82cUAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OTaWN-yeCAqiOI9rf8heM_q3a_qfqjca4uQ3VbQ7W82cUAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241118A02JBX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241118A02JBX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["JG","BK4587","06681","BK4023"],"gpt_icon":0},{"id":"2481192208","title":"腦動極光：3年半虧損近17億 商業化早期難掩盈利焦慮","url":"https://stock-news.laohu8.com/highlight/detail?id=2481192208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481192208?lang=zh_tw&edition=fundamental","pubTime":"2024-11-07 17:04","pubTimestamp":1730970285,"startTime":"0","endTime":"0","summary":"近期，脑动极光医疗科技有限公司(以下简称：脑动极光)通过港交所主板上市聆讯，中金公司及浦银国际为其联席保荐人。“脑科学+AI”无疑成为脑动极光的最大亮点，也足以让资本市场投注目光。 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241107/c663294572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["06681"],"gpt_icon":0},{"id":"2481924062","title":"新股解讀|腦動極光：3年半虧損近17億  商業化早期難掩盈利焦慮","url":"https://stock-news.laohu8.com/highlight/detail?id=2481924062","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481924062?lang=zh_tw&edition=fundamental","pubTime":"2024-11-07 16:59","pubTimestamp":1730969963,"startTime":"0","endTime":"0","summary":"值得关注的是，尽管脑动极光作为业内商业化收入最高的玩家，但仍掩不住变现焦虑。3年半亏损近17亿血管性、神经退行性以及儿童发育缺陷等疾病诱发的认知障碍症一直都缺乏必要的药物治疗，心理干预评估是主流的治疗方式之一。截至2024年10月22日，脑动极光医疗的系统已纳入中国30 个省份的省级医保报销目录。但对应到脑动极光来说，公司仍处于商业化早期阶段，亏损或仍是投资者观望的一大原因。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06681","BK4587","BK4023","JG"],"gpt_icon":0},{"id":"2480888475","title":"新股消息丨腦動極光通過港交所聆訊 深耕認知障礙數字療法市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2480888475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480888475?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 20:45","pubTimestamp":1730465158,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/JFUGI1SV05198UNI.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/JFUGI1SV05198UNI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["06681"],"gpt_icon":0},{"id":"2480885851","title":"腦動極光通過港交所聆訊 深耕認知障礙數字療法市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2480885851","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480885851?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 20:39","pubTimestamp":1730464793,"startTime":"0","endTime":"0","summary":"据港交所10月31日消息，脑动极光医疗科技有限公司(简称：脑动极光)通过港交所主板上市聆讯，中金公司及浦银国际为其联席保荐人。招股书显示，脑动极光医疗成立于2012年，产品管线涵盖由血管 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241101/c663108408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["06681"],"gpt_icon":0},{"id":"2480000437","title":"新股消息丨腦動極光通過港交所聆訊 深耕認知障礙數字療法市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2480000437","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480000437?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 20:25","pubTimestamp":1730463901,"startTime":"0","endTime":"0","summary":"截至2024年10月22日，脑动极光医疗的系统已纳入中国30 个省份的省级医保报销目录。根据弗若斯特沙利文的资料，脑动极光医疗也是国家卫健委所发起项目的首家承办单位，公司在该项目下的任务是帮助国家卫健委在全国推动2100多家公立医院建立认知中心，并促进中国认知障碍数字疗法市场的发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JG","BK4587","BK4023","06681"],"gpt_icon":0},{"id":"2480070744","title":"腦動極光通過上市聆訊：上半年營收5189萬 虧損1.14億","url":"https://stock-news.laohu8.com/highlight/detail?id=2480070744","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480070744?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 17:57","pubTimestamp":1730455020,"startTime":"0","endTime":"0","summary":"脑动极光2024年上半年营收为5189万元，上年同期的营收为2441万元；毛利为2452万元，上年同期的毛利为1210万元；期内亏损为1.14亿元，上年同期的期内亏损为2.35亿元。脑动极光2021年、2022年、2023年经调整净亏损分别为5470万元、1.17亿元、1.49亿元。脑动极光2024年上半年经调整亏损为7884万元，上年同期的经调整亏损为7103万元。截至2024年6月30日，脑动极光持有的现金及现金等价物为5591万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2024-11-01/doc-incuqfsy3090809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06681","JG"],"gpt_icon":0},{"id":"2480502050","title":"腦動極光-B再次通過聆訊 或很快香港上市 中金、浦銀聯席保薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2480502050","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480502050?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 13:28","pubTimestamp":1730438880,"startTime":"0","endTime":"0","summary":"　　2024年10月31日，来自浙江绍兴的脑动极光医疗科技有限公司BrainAurora Medical Technology Limited向港交所重新递表，并更新聆讯后的招股书，获很快在香港主板IPO上市。　　脑动极光的产品管线涵盖由血管疾病、神经退行性疾病、精神疾病、儿童发育缺陷等诱发的广泛的认知障碍的测评和干预。　　脑动极光的核心产品已纳入中国30个省份的省级医保报销目录。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2024-11-01/doc-incupzky6373160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["JG","06681","BK4587","BK4023"],"gpt_icon":0},{"id":"2480040987","title":"腦動極光上市聆訊獲通過 擬於港交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2480040987","media":"中国上市公司网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480040987?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 12:40","pubTimestamp":1730436001,"startTime":"0","endTime":"0","summary":"中国上市公司网讯 10月31日，脑动极光医疗科技有限公司(以下简称“脑动极光”)上市聆讯获通过，公司将登陆港交所主板上市。公开数据显示，脑动极光成立于2012年。公司的产品管线涵盖由血管 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241101/c663069933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["06681"],"gpt_icon":0},{"id":"2480374090","title":"【新股IPO】腦動極光醫療科技通過港交所上市聆訊","url":"https://stock-news.laohu8.com/highlight/detail?id=2480374090","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480374090?lang=zh_tw&edition=fundamental","pubTime":"2024-11-01 08:04","pubTimestamp":1730419487,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所10月31日披露，脑动极光医疗科技通过港交所上市聆讯，中金公司、浦银国际为联席保荐人。公司成立于2012年，公司产品管线涵盖由血管疾病、神经退行性疾病、精神疾病及儿童发育缺陷等诱发的广泛的认知障碍的测评和干预。财务方面，公司于2021年、2022年及2023年以及截至2023年及2024年6月30日止六个月，收入分别为229.9万、1129.1万、6720万、2441.2万及5188.7万人民币；公司拥有人应占亏损分别为6.98亿、5.02亿、3.59亿、2.35亿及1.14亿元人民币。","market":"nz","thumbnail":"https://static.szfiu.com/news/20220324/MmFjZGExNjQxMjAyMjczMTQ1Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/MmFjZGExNjQxMjAyMjczMTQ1Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1946904","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JG","06681","BK4587","BK4023","159891"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06681\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"06681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06681\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06681\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06681\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06681","date":"2025-04-17","current":-35.344802,"percent":0.179104,"low":-129.370062,"twenty":-34.78289,"median":-29.886916,"eighty":-24.032177,"high":-17.925235,"avg":-31.435968,"sd":13.410404,"marketCap":7445714640},"quantilePoints":[{"date":"2025-01-10","current":-21.981958,"twenty":-86.41482,"median":-21.981958,"eighty":-21.802105,"marketCap":5571623200},{"date":"2025-01-17","current":-18.56976,"twenty":-21.862056,"median":-19.271526,"eighty":-18.260929,"marketCap":4710554160},{"date":"2025-01-24","current":-23.018051,"twenty":-22.807821,"median":-21.682203,"eighty":-18.511705,"marketCap":5875529920},{"date":"2025-01-28","current":-21.723738,"twenty":-22.688978,"median":-21.723738,"eighty":-18.550408,"marketCap":5571623200},{"date":"2025-02-07","current":-27.941716,"twenty":-25.77454,"median":-22.285933,"eighty":-19.692586,"marketCap":7129145140},{"date":"2025-02-14","current":-29.252327,"twenty":-27.489215,"median":-22.926663,"eighty":-20.162257,"marketCap":7445714640},{"date":"2025-02-21","current":-31.566644,"twenty":-28.929981,"median":-25.55594,"eighty":-21.387662,"marketCap":8078853640},{"date":"2025-02-28","current":-29.834302,"twenty":-29.391701,"median":-26.886113,"eighty":-21.715431,"marketCap":7610330780},{"date":"2025-03-07","current":-29.22057,"twenty":-29.502461,"median":-27.62349,"eighty":-21.902836,"marketCap":7483702980},{"date":"2025-03-14","current":-34.00413,"twenty":-30.145152,"median":-27.941716,"eighty":-21.975088,"marketCap":8711992640},{"date":"2025-03-21","current":-34.462483,"twenty":-31.994702,"median":-28.934742,"eighty":-22.468319,"marketCap":8825957660},{"date":"2025-03-28","current":-34.829628,"twenty":-33.432151,"median":-29.22057,"eighty":-22.621627,"marketCap":8901934340},{"date":"2025-04-03","current":-40.682101,"twenty":-33.957372,"median":-29.288545,"eighty":-22.807821,"marketCap":8636015960},{"date":"2025-04-11","current":-36.776004,"twenty":-34.343013,"median":-29.6034,"eighty":-22.981496,"marketCap":7736958580},{"date":"2025-04-17","current":-35.344802,"twenty":-34.78289,"median":-29.886916,"eighty":-24.032177,"marketCap":7445714640}],"updateTime":1745156680981}}}